Jacqualyn A. Fouse

2021 - Agios Pharmaceuticals

In 2021, Jacqualyn A. Fouse earned a total compensation of $6.5M as Chief Executive Officer at Agios Pharmaceuticals, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$543,400
Option Awards$5,202,524
Salary$760,000
Other$13,503
Total$6,519,427

Fouse received $5.2M in option awards, accounting for 80% of the total pay in 2021.

Fouse also received $543.4K in non-equity incentive plan, $760K in salary and $13.5K in other compensation.

Rankings

In 2021, Jacqualyn A. Fouse's compensation ranked 1,920th out of 12,412 executives tracked by ExecPay. In other words, Fouse earned more than 84.5% of executives.

ClassificationRankingPercentile
All
1,920
out of 12,412
85th
Division
Manufacturing
725
out of 5,498
87th
Major group
Chemicals And Allied Products
277
out of 2,374
88th
Industry group
Drugs
236
out of 2,095
89th
Industry
Pharmaceutical Preparations
156
out of 1,542
90th

Pay ratio

Jacqualyn A. Fouse's Pay$6,519,427
Median Employee's Pay$315,091
Pay Ratio

21

to 1

In 2021, the annual total compensation of Jacqualyn A. Fouse was $6,519,427.

The annual total compensation of the median employee at Agios Pharmaceuticals was $315,091.

The ratio of Jacqualyn A. Fouse's pay to the pay of median employee was therefore 21 to one.

Source: SEC filing on April 28, 2022.

Fouse's colleagues

We found six more compensation records of executives who worked with Jacqualyn A. Fouse at Agios Pharmaceuticals in 2021.

2021

Jonathan Biller

Agios Pharmaceuticals

Chief Financial Officer

2021

Bruce Car

Agios Pharmaceuticals

Chief Scientific Officer

2021

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2021

Darrin Miles

Agios Pharmaceuticals

Former Chief Commercial Officer

2021

Sarah Gheuens

Agios Pharmaceuticals

Chief Medical Officer

2021

Richa Poddar

Agios Pharmaceuticals

Chief Commercial Officer

News

In-depth

You may also like